Condition
Alzheimer's Dementia (AD)
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Completed2
Not Yet Recruiting1
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07757204Phase 2Not Yet RecruitingPrimary
An Open-label Long-term Safety Study of Buntanetap in Participants With AD
NCT07594665Enrolling By Invitation
Expanding Access to Cognitive Health Biomarker Testing at Home
NCT05254873CompletedPrimary
Long-term Follow-up of Patients Included in the EYE-TAR(MA) Study.
NCT05267028CompletedPrimary
Rehabilitation of Facial Emotion Recognition in Alzheimer's Disease
Showing all 4 trials